United Kingdom

Hikma continues strong momentum across the Group and upgrades guidance for 2023

• .

Hikma continues strong momentum across the Group and upgrades guidance for 2023

AETOSWire 2 November، 2023

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update...

Read More Read more about Hikma continues strong momentum across the Group and upgrades guidance for 2023

TaCa Healthcare is revolutionizing the healthcare industry by making elective secondary care surgeries more affordable and accessible.

• Health and Beauty

TaCa Healthcare is revolutionizing the healthcare industry by making elective secondary care surgeries more affordable and accessible.

AETOSWire 19 October، 2023

London, United Kingdom — Founded by Bidhan Chowdhury and Abhinav Sharma, this healthcare startup has developed an...

Read More Read more about TaCa Healthcare is revolutionizing the healthcare industry by making elective secondary care surgeries more affordable and accessible.

Good momentum across all businesses and updated Generics guidance

• .

Good momentum across all businesses and updated Generics guidance

AETOSWire 29 April، 2023

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update...

Read More Read more about Good momentum across all businesses and updated Generics guidance

Riad Mishlawi named Chief Executive Officer of Hikma Pharmaceuticals PLC

• .

Riad Mishlawi named Chief Executive Officer of Hikma Pharmaceuticals PLC

AETOSWire 12 April، 2023

Amman,Jordan, 12 April 2023 — Hikma Pharmaceuticals PLC (Hikma, Group), announces that Riad Mishlawi, President of the...

Read More Read more about Riad Mishlawi named Chief Executive Officer of Hikma Pharmaceuticals PLC

Hikma reiterates full year segmental guidance, with strong momentum in Injectables and Branded

• .

Hikma reiterates full year segmental guidance, with strong momentum in Injectables and Branded

AETOSWire 3 November، 2022

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update...

Read More Read more about Hikma reiterates full year segmental guidance, with strong momentum in Injectables and Branded

Collaboration between Al Hokair Group and IMPS to launch the first Smurfs FEC in the Mena region

• .

Collaboration between Al Hokair Group and IMPS to launch the first Smurfs FEC in the Mena region

AETOSWire 19 October، 2022

ExCel London, United Kingdom — The recently concluded, Brand Licensing Europe tradeshow witnessed the signing of a license...

Read More Read more about Collaboration between Al Hokair Group and IMPS to launch the first Smurfs FEC in the Mena region

Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region

• .

Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region

AETOSWire 18 July، 2022

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces an exclusive licensing agreement...

Read More Read more about Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region